Ravi Misra
Stock Analyst at Truist Financial
(0.49)
# 4,217
Out of 4,595 analysts
41
Total ratings
35%
Success rate
-10.7%
Average return
Main Sectors:
Stocks Rated by Ravi Misra
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KIDS OrthoPediatrics | Maintained: Hold | $17 → $20 | $20.19 | -0.94% | 2 | Jul 17, 2026 | |
| IART Integra LifeSciences Holdings | Maintained: Hold | $14 → $19 | $16.65 | +14.11% | 4 | Jul 16, 2026 | |
| ORGO Organogenesis Holdings | Initiated Coverage: Hold | $3 | $2.37 | +26.58% | 1 | May 28, 2026 | |
| TFX Teleflex | Reiterated: Hold | $135 → $143 | $136.71 | +4.60% | 2 | May 11, 2026 | |
| ALGN Align Technology | Rated: Hold | n/a | $169.16 | n/a | 4 | Dec 13, 2021 | |
| DXCM DexCom | Rated: Hold | n/a | $83.45 | n/a | 2 | Dec 13, 2021 | |
| PODD Insulet | Rated: Hold | n/a | $165.35 | n/a | 3 | Dec 13, 2021 | |
| TNDM Tandem Diabetes Care | Rated: Hold | n/a | $19.50 | n/a | 2 | Dec 13, 2021 | |
| GKOS Glaukos | Rated: Hold | n/a | $166.72 | n/a | 2 | Dec 13, 2021 | |
| TDOC Teladoc Health | Rated: Hold | n/a | $6.71 | n/a | 7 | Dec 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $50.21 | n/a | 5 | Dec 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.9799 | n/a | 2 | Dec 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $10.75 | n/a | 4 | Dec 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $283 | $353.33 | n/a | 1 | Apr 19, 2017 |
OrthoPediatrics
Jul 17, 2026
Maintained: Hold
Price Target: $17 → $20
Current: $20.19
Upside: -0.94%
Integra LifeSciences Holdings
Jul 16, 2026
Maintained: Hold
Price Target: $14 → $19
Current: $16.65
Upside: +14.11%
Organogenesis Holdings
May 28, 2026
Initiated Coverage: Hold
Price Target: $3
Current: $2.37
Upside: +26.58%
Teleflex
May 11, 2026
Reiterated: Hold
Price Target: $135 → $143
Current: $136.71
Upside: +4.60%
Align Technology
Dec 13, 2021
Rated: Hold
Price Target: n/a
Current: $169.16
Upside: n/a
DexCom
Dec 13, 2021
Rated: Hold
Price Target: n/a
Current: $83.45
Upside: n/a
Insulet
Dec 13, 2021
Rated: Hold
Price Target: n/a
Current: $165.35
Upside: n/a
Tandem Diabetes Care
Dec 13, 2021
Rated: Hold
Price Target: n/a
Current: $19.50
Upside: n/a
Glaukos
Dec 13, 2021
Rated: Hold
Price Target: n/a
Current: $166.72
Upside: n/a
Teladoc Health
Dec 13, 2021
Rated: Hold
Price Target: n/a
Current: $6.71
Upside: n/a
Dec 13, 2021
Rated: Hold
Price Target: n/a
Current: $50.21
Upside: n/a
Dec 13, 2021
Rated: Hold
Price Target: n/a
Current: $0.9799
Upside: n/a
Dec 13, 2021
Rated: Hold
Price Target: n/a
Current: $10.75
Upside: n/a
Apr 19, 2017
Reiterated: Buy
Price Target: $283
Current: $353.33
Upside: n/a